The work analyses the results of treating 20 hypertensive patients with (stage I-II) with betapressin. The drug is shown to be active in causing a significant decrease of systolic and mean arterial pressure. Its hypotensive effect is associated with essential decrease of peripheral vascular resistance. This circumstance, as well as acceleration of the heart rhythm, leads to increase of the cardiac output. Betapressin is recommended for monotherapy of patients suffering from stages I-II hypertension with eu- and hypokinetic types of hemodynamics.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[the pharmacological
4
pharmacological betapressin
4
betapressin hypertension]
4
hypertension] work
4
work analyses
4
analyses treating
4
treating hypertensive
4
hypertensive patients
4
patients stage
4
stage i-ii
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!